Treatment of Neuromyelitis Optica: Review and Recommendations.
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...
Auteurs principaux: | Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, de Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
Treatment of neuromyelitis optica: Review and recommendations
par: Kimbrough, D, et autres
Publié: (2012) -
Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
par: Pittock, S, et autres
Publié: (2019) -
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
par: Jyh Yung Hor, et autres
Publié: (2020-06-01) -
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
par: Mealy, M, et autres
Publié: (2014) -
Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
par: Fujihara, K, et autres
Publié: (2014)